Clinical Trials on Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis

Total 3445 results

Novartis Pharmaceuticals

Completed

Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064

Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis

Netherlands, Germany
Bionorica SE

Completed

Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis

Eczema-Prone Skin | Atopic Diathesis

Germany
Xencor, Inc.
ICON Early Phase Services, LLC

Completed

Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195

Healthy Volunteers | Atopic Disease

United States
Amgen

Completed

Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Healthy Volunteers | Atopic Dermatitis
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Atopic Dermatitis (AD) and Food Allergy

Atopic Dermatitis (AD) | Non-atopic Healthy Controls

United States
National Jewish Health
Genentech, Inc.

Recruiting

Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum

Atopic Dermatitis With a History of Eczema Herpeticum | Atopic Dermatitis Without a History of Eczema Herpeticum | Health Controls Without Atopy

United States
Bristol-Myers Squibb

Completed

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Healthy Subjects and Atopic Dermatitis Subjects

United Kingdom
Catalysis SL

Completed

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions | Atopic Dermatitis \(AD\)

Serbia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
Innovaderm Research Inc.

Completed

Development of a Method to Measure mRNA Levels in Skin Samples

Healthy | Psoriasis | Atopic Dermatitis Eczema

Canada
Rigshospitalet, Denmark
Oslo University Hospital

Recruiting

Ocular Comorbidity in Atopic Dermatitis

Atopic Keratoconjunctivitis

Denmark
Jacob Pontoppidan Thyssen
The Novo Nordic Foundation

Recruiting

Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis Flare

Denmark
University of California, San Francisco
Sanofi; Regeneron Pharmaceuticals

Recruiting

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Eczema | Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis and Related Conditions

United States
Shaperon

Recruiting

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Atopic Dermatitis | Atopic Dermatitis Eczema | Atopic Dermatitis of Scalp

United States
Pfizer

Active, not recruiting

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Eczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, Unspecified

United States, Canada, Czechia, Poland
Oregon Health and Science University
University of Colorado, Denver; University of Wisconsin, Madison; Duke University

Active, not recruiting

A Community-based Assessment of Skin Care, Allergies, and Eczema (CASCADE)

Eczema | Atopic Dermatitis | Atopic Eczema | Atopic Disorders

United States
Regeneron Pharmaceuticals
Sanofi

Recruiting

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial (DISCOVER)

Moderate-to-Severe Atopic Dermatitis | Atopic Eczema

United States
Johnson & Johnson Consumer Inc. (J&JCI)
Infinant Health, Inc. (formerly known as Evolve BioSystems, Inc.)

Active, not recruiting

A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

Healthy

Finland
Amgen

Completed

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic Dermatitis

Canada, United States, Japan
Sanofi

Completed

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China (BALISTAD-CN)

Atopic Dermatitis | Dermatitis Atopic

China
Sanofi

Completed

A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries (AD-impaCT)

Dermatitis Atopic

Saudi Arabia, Kuwait, United Arab Emirates
Eli Lilly and Company

Recruiting

A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Healthy | Atopic Dermatitis

Japan, United States
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
Galapagos NV

Terminated

A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

Healthy | Atopic Dermatitis

Spain, Germany, Ukraine, United Kingdom
Hadassah Medical Organization

Unknown

Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic Dermatitis

ATOPIC DERMATITIS
SymmetryScience Group, Inc.

Completed

Atopic Dermatitis With Accelerometry and Polysomnography (ADAP) (ADAP)

Healthy | Eczema | Atopic Dermatitis

United States
University of Miami

Completed

Stress-induced Scratching in Healthy and AD

Healthy | Atopic Dermatitis

United States
Pfizer

Completed

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

Healthy | Atopic Dermatitis

Japan
AnaptysBio, Inc.

Recruiting

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Atopic Dermatitis Eczema

United States, Canada, Georgia, New Zealand
Imperial College London
JP Moulton Charitable Foundation

Recruiting

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Atopic Dermatitis Eczema

United Kingdom
University of California, Irvine
Pfizer

Completed

Characterizing Skin Microbiome Change in Atopic Dermatitis

Atopic Dermatitis | Atopic Dermatitis Eczema

United States
Pfizer
In Expanded Access, treating physicians are the Sponsor

Available

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Severe Uncontrolled Atopic Dermatitis
Evommune, Inc.

Completed

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Atopic Dermatitis Eczema

United States
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
University of California, San Diego

Completed

Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

Atopic Dermatitis Eczema

United States
Novartis Pharmaceuticals

Completed

Verification Study of Ciclosporin for Atopic Dermatitis

Severe Atopic Dermatitis
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Atopic Dermatitis (AD)

United States
AbbVie

Active, not recruiting

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Atopic Dermatitis (AD)

China
National Institute of Allergy and Infectious Diseases...
Sanofi; Regeneron Pharmaceuticals; Rho Federal Systems Division, Inc.; Atopic Dermatitis...

Terminated

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Atopic Dermatitis (AD)

United States
AbbVie

Withdrawn

A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Atopic Dermatitis (AD)
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Atopic Dermatitis (AD)

United States, Canada
Academisch Medisch Centrum - Universiteit van Amsterdam...
Erasmus Medical Center; Prothya Biosolutions

Recruiting

DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema (DUPI REDUCE)

Atopic Dermatitis | Atopic Dermatitis Eczema

Netherlands
SunWay Biotech Co., LTD.

Not yet recruiting

The Efficacy of NTU 101 Lactic Acid Bacteria Powder in the Adjuvant Improvement of Atopic Dermatitis Clinical Trial

Atopic Dermatitis | Atopic Dermatitis Eczema
KK Women's and Children's Hospital

Not yet recruiting

Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis

Atopic Dermatitis Eczema
Arcutis Biotherapeutics, Inc.

Active, not recruiting

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

Atopic Dermatitis Eczema

United States, Canada
Arcutis Biotherapeutics, Inc.

Completed

Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

Atopic Dermatitis Eczema

United States, Canada
Fresh Tracks Therapeutics, Inc.
Syneos Health; Innovaderm Research Inc.

Terminated

A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis

Atopic Dermatitis Eczema

Canada
AOBiome LLC
Veristat, Inc.

Completed

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States

Clinical Trials on Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations